[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Colquhoun et al., 1974 - Google Patents

Metabolism of rat α1-fetoprotein

Colquhoun et al., 1974

Document ID
3685669734498514879
Author
Colquhoun B
Gold P
Barzell W
Oakes D
Shuster J
Publication year
Publication venue
Cancer Research

External Links

Snippet

The pattern of α1-fetoprotein (AFP) disappearance from the rat circulation has been examined by radioimmunoassay in females in both the postpartum and postabortion periods, in males and nulliparous females infused with AFP-rich rat amniotic fluid, and in …
Continue reading at aacrjournals.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Holguin et al. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.
Rorie et al. Histologic and chemical studies of the smooth muscle in the human cervix and uterus
HOOKER et al. The transport of progesterone in blood
Isles et al. Glucose tolerance and plasma insulin in newborn infants of normal and diabetic mothers
MacPhail et al. The relationship between maternal and infant iron status
US3236732A (en) Pregnancy test method and immunological indicator therefor
Chesley Parenteral magnesium sulfate and the distribution, plasma levels, and excretion of magnesium
Colquhoun et al. Metabolism of rat α1-fetoprotein
FORSLING et al. Observations on the release and clearance of neurophysin and the neurohypophysial hormones in the rat
Flexner et al. The measurement of placental permeability with radioactive sodium: the relation of placental permeability to fetal size in the rat
Holdaway et al. Circulating corticotrophin levels in severe hypopituitarism and in the neonate
Cassels Jr et al. Reduced metabolic clearance of acidic variants of human choriogonadotropin from patients with testicular cancer
Marks et al. Iron metabolism in skin disease
Keane et al. Binding characteristics of transcortin in human plasma in normal individuals, pregnancy and liver disease
Jelen et al. The possible relation between late pregnancy hypertension and 5‐hydroxytryptamine levels in maternal blood
Dyckner et al. Intracellular potassium after magnesium infusion.
SOBEL et al. Hypervolemia in mice bearing granulosa cell growths; time of onset and some associated physiological and chemical changes
Rapaport Plasma thromboplastin antecedent levels in patients receiving coumarin anticoagulants and in patients with Laennec's cirrhosis.
Barr et al. Studies of the anemia in ulcerative colitis with special reference to the iron metabolism
Cornford et al. Protein, glycogen, and water content in schistosomes
McKiLLOP et al. SEQUENTIAL STUDIES IN PRE‐ECLAMPSIA USING PLASMA FIBRINOGEN CHROMATOGRAPHY
Jokinson et al. Antitissue antibodies in monozygotic twins with systemic lupus erythematosus.
Brummund et al. Alpha-fetoprotein in the routine clinical laboratory: Evaluation of a simple radioimmunoassay and review of current concepts in its clinical application
Cowett et al. Blunted muscle responsiveness to insulin in the neonatal rat
Gundersen et al. Effect of Heparin on Insulin-like Activity in Rat Bioassay: Comparison between Rat Diaphragm and Epididymal Fat Pad Assay in Normal and Untreated Diabetic Subjects